Company / PP&E (Net)
Bio-Techne PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$245.7M
FY2025
5-year range
$207.9M / $251.2M
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
#63 of 132
Health Care
What the data says
At $246M, Bio-Techne's pp&e (net) ranks #63 of 132 in the Health Care sector. Improved from $226M to $246M over the past 2 years.
Based on SEC 10-K filings.
$246M in FY2025 with a 5-year CAGR of +6.8%.
Improved from $226M to $246M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +3.2%
- 5-Year CAGR
- +6.8%
- 10-Year CAGR
- -
Sector benchmark
#63 of 132 in Health CareTop 48% of 132This company $245.7M Sector average $1.4B
▼
-82.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.8%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 2.2% year-over-year.
- Ranks #63 out of 132 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $245.7M | -2.2% |
| FY2024 | $251.2M | +11.0% |
| FY2023 | $226.2M | +1.3% |
| FY2022 | $223.2M | +7.4% |
| FY2021 | $207.9M | +17.6% |
| FY2020 | $176.8M | +14.8% |
| FY2019 | $154.0M | +6.0% |
| FY2018 | $145.3M | +7.6% |
| FY2017 | $135.1M | +2.1% |
| FY2016 | $132.4M | +2.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026